Aveanna Healthcare Holdings Inc. (AVAH)
USD 4.53
(-0.66%)
USD 4.53
(-0.66%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 587.36 Million USD | -10.15% |
| 2022 | 520.05 Million USD | 16.09% |
| 2021 | 447.98 Million USD | 20.2% |
| 2020 | 372.71 Million USD | 4.22% |
| 2019 | 357.63 Million USD | 5.28% |
| 2018 | 339.71 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 116.81 Million USD | 3.53% |
| 2024 Q2 | 116.22 Million USD | -0.5% |
| 2023 Q1 | 64.88 Million USD | -49.33% |
| 2023 FY | 467.27 Million USD | -10.15% |
| 2023 Q4 | 112.83 Million USD | -4.42% |
| 2023 Q3 | 118.05 Million USD | 0.22% |
| 2023 Q2 | 117.79 Million USD | 81.54% |
| 2022 Q2 | 116.32 Million USD | -11.18% |
| 2022 Q1 | 130.95 Million USD | 17.26% |
| 2022 Q4 | 128.06 Million USD | 21.78% |
| 2022 FY | 520.05 Million USD | 16.09% |
| 2022 Q3 | 105.16 Million USD | -9.59% |
| 2021 Q4 | 111.68 Million USD | -6.45% |
| 2021 FY | 447.98 Million USD | 20.2% |
| 2021 Q3 | 119.38 Million USD | 3.55% |
| 2021 Q1 | 101.61 Million USD | -1.92% |
| 2021 Q2 | 115.29 Million USD | 13.45% |
| 2020 FY | 372.71 Million USD | 4.22% |
| 2020 Q4 | 103.6 Million USD | 7.09% |
| 2020 Q3 | 96.74 Million USD | 16.99% |
| 2020 Q2 | 82.69 Million USD | -7.79% |
| 2020 Q1 | 89.67 Million USD | 0.0% |
| 2019 FY | 357.63 Million USD | 5.28% |
| 2018 FY | 339.71 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | -233.703% |
| Addus HomeCare Corporation | 248.92 Million USD | -135.963% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | -396.408% |
| Amedisys, Inc. | 834.47 Million USD | 29.614% |
| American Oncology Network, Inc. | 83.97 Million USD | -599.446% |
| Astrana Health, Inc. | 112.59 Million USD | -421.648% |
| IMAC Holdings, Inc. | 5.02 Million USD | -11583.813% |
| biote Corp. | 98.82 Million USD | -494.338% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -1568.38% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | -73.931% |
| COMPASS Pathways plc | 136.91 Million USD | -328.984% |
| DocGo Inc. | 180.32 Million USD | -225.719% |
| The Ensign Group, Inc. | 335.39 Million USD | -75.126% |
| Healthcare Services Group, Inc. | 189.09 Million USD | -210.621% |
| InnovAge Holding Corp. | 558.25 Million USD | -5.214% |
| Assure Holdings Corp. | 15.43 Million USD | -3704.391% |
| The Joint Corp. | 109.22 Million USD | -437.763% |
| LifeStance Health Group, Inc. | 491.23 Million USD | -19.569% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -3119.802% |
| ModivCare Inc. | 586.89 Million USD | -0.079% |
| NewGenIvf Group Limited | 1.63 Million USD | -35724.617% |
| Novo Integrated Sciences, Inc. | 13.5 Million USD | -4248.922% |
| Option Care Health, Inc. | 666.62 Million USD | 11.891% |
| P3 Health Partners Inc. | 199.56 Million USD | -194.32% |
| P3 Health Partners Inc. | 199.56 Million USD | -194.32% |
| The Pennant Group, Inc. | 88.99 Million USD | -559.992% |
| Surgery Partners, Inc. | 319.5 Million USD | -83.837% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -13561.127% |
| Talkspace, Inc. | 97.58 Million USD | -501.871% |
| Talkspace, Inc. | 97.58 Million USD | -501.871% |
| The Oncology Institute, Inc. | 136.59 Million USD | -330.014% |
| The Oncology Institute, Inc. | 136.59 Million USD | -330.014% |